(Q33944298)

30 July 2017

title

NSAIDs inhibit neovascularization of choroid through HO-1-dependent pathway (English)

1 reference

30 July 2017

1 reference

Narimasa Yoshinaga

1

1 reference

30 July 2017

Noboru Arimura

2

1 reference

30 July 2017

Hiroki Otsuka

3

1 reference

30 July 2017

Ko-Ichi Kawahara

4

1 reference

30 July 2017

Teruto Hashiguchi

5

1 reference

30 July 2017

Ikuro Maruyama

6

1 reference

30 July 2017

Taiji Sakamoto

7

1 reference

30 July 2017

publication date

27 June 2011

1 reference

30 July 2017

published in

Laboratory Investigation

1 reference

30 July 2017

volume

91

1 reference

30 July 2017

issue

9

1 reference

30 July 2017

page(s)

1277-1290

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.2011.101

30 July 2017

exact match

0 references

cites work

Choroidal neovascularization in pathologic myopia: recent developments in diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Etiology of choroidal neovascularization in young patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Ranibizumab for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Inhibition of choroidal neovascularization via brief subretinal exposure to a newly developed lentiviral vector pseudotyped with Sendai viral envelope proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Effect of intravitreal administration of indomethacin on experimental subretinal neovascularization in the subhuman primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

COX-2-selective inhibitor, etodolac, suppresses choroidal neovascularization in a mice model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Topical nepafenac inhibits ocular neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

The effects of nepafenac and amfenac on retinal angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Inhibition of choroidal neovascularization by intravitreal ketorolac

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Ketorolac inhibits choroidal neovascularization by suppression of retinal VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Reduced choroidal neovascular membrane formation in cyclooxygenase-2 null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

The heme oxygenase system: a regulator of second messenger gases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Heme oxygenase-1 induction by nitric oxide in RAW 264.7 macrophages is upregulated by a cyclo-oxygenase-2 inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Celecoxib induces heme-oxygenase expression in glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Heme oxygenase-1 induction may explain the antioxidant profile of aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Induction of hepatic heme oxygenase-1 by diclofenac in rodents: role of oxidative stress and cytochrome P-450 activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Intraocular expression and release of high-mobility group box 1 protein in retinal detachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Stromal cell-derived factor-1 is essential for photoreceptor cell protection in retinal detachment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Choroidal neovascularization enhanced by Chlamydia pneumoniae via Toll-like receptor 2 in the retinal pigment epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/flt-1 receptor gene transfection: a role of VEGF and possible treatment for SRN in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Nrf2 signaling in coordinated activation of antioxidant gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Nrf2:INrf2 (Keap1) signaling in oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Divergent responses of chondrocytes and endothelial cells to shear stress: cross-talk among COX-2, the phase 2 response, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Complex role of heme oxygenase-1 in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Dual role of VEGF-induced heme-oxygenase-1 in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Curcumin protects retinal cells from light-and oxidant stress-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Viral delivery of heme oxygenase-1 attenuates photoreceptor apoptosis in an experimental model of retinal detachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Retinal protection from acute glaucoma-induced ischemia-reperfusion injury through pharmacologic induction of heme oxygenase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Protection of RPE cells from oxidative injury by 15-deoxy-delta12,14-prostaglandin J2 by augmenting GSH and activating MAPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

Age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

7 January 2021

Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

7 January 2021

Heme oxygenase-1 protects gastric mucosal cells against non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

7 January 2021

von Hippel Lindau tumor suppressor and HIF-1alpha: new targets of NSAIDs inhibition of hypoxia-induced angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

7 January 2021

The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.101

7 January 2021

10.1038/LABINVEST.2011.101

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1013065783

0 references

Fatcat ID

release_bv6yneesrfgjpop3f2d7ahe6p4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bv6yneesrfgjpop3f2d7ahe6p4

24 November 2022

mapped directly with Wikidata item

1 reference